Company / Current Assets
Mineralys Therapeutics, Inc. Current Assets History
FY2022-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Assets
$205.4M
FY2024
5-year range
$112.8M / $249.1M
FY2022-FY2024
Trend
-17.6%
vs FY2023
Sector context
#188 of 213
Health Care
What the data says
Mineralys Therapeutics, Inc.'s current assets of $205M is lower than 88% of companies in the Health Care sector (FY2024). Improved from $113M to $205M over the past 2 years.
Based on SEC 10-K filings.
$205M in FY2024.
Improved from $113M to $205M over the past 2 years.
Health Care sector context is included.
Current Assets over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 12% in Health CareTop 88% of 213This company $205.4M Sector average $2.5B
▼
-91.9% below sector average
Key checks
Key Insights
- In FY2024, current assets decreased 17.6% year-over-year.
- Ranks #188 out of 213 companies in the Health Care sector.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 3.25 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $205.4M | -17.6% |
| FY2023 | $249.1M | +120.8% |
| FY2022 | $112.8M | - |
As of FY2024 · SEC 10-K · Updated Feb 28, 2026